Inactive Instrument

Insiders Liminal BioSciences Inc. Toronto S.E.

Equities

Liminal BioSciences Inc. Appoints Gary Bridger as Interim Chief Scientific	09/11/22	CI
Liminal Biosciences Inc. Announces Executive Changes	07/09/21	CI
Liminal BioSciences Inc. Announces Executive Changes	12/11/20	CI
Liminal BioSciences Inc. Announces Management Changes	12/11/20	CI
Liminal Biosciences Inc. Announces Board Changes	01/09/20	CI
Liminal Biosciences Inc. Appoints Stefan Clulow as Director	09/06/20	CI
Liminal Biosciences Inc. Announces Board Changes	13/11/19	CI
Prometic Life Sciences Inc. has Changed its Name to Liminal BioSciences Inc	03/10/19	CI
Prometic Life Sciences Inc. Announces Executive Promotions, Effective September 1, 2019	13/08/19	CI
Prometic Life Sciences Inc. Announces Board Changes	08/05/19	CI
Prometic Life Sciences Inc. Announces Board and Executive Changes	23/04/19	CI
Prometic Life Sciences Inc. Announces Management Changes	19/12/18	CI
ProMetic Life Sciences Inc. Appoints Kory Sorenson as Non-Executive Director	10/05/18	CI
Prometic Life Sciences Inc. Appoints Bruce Wendel as Chief Business Development Officer	03/04/18	CI
ProMetic Life Sciences Inc. Appoints Ken Galbraith to its Board of Directors	11/08/16	CI
ProMetic Life Sciences Inc. Appoints Gregory Weaver as Chief Financial Officer	02/11/15	CI
ProMetic Life Sciences Inc. Announces Management Changes	12/08/14	CI
Prometic Life Sciences Inc. Elects Simon Best as Chairman of the Board	14/05/14	CI
ProMetic Announces Appointment of John Moran as New Chief Medical Officer	06/02/14	CI
ProMetic Life Sciences Inc. Announces Board Changes	14/11/13	CI

No results for this search